RESUMEN

Delirium is a common, serious, and often preventable neuropsychiatric emergency mostly characterized by a disturbance in attention and awareness. Systemic insult and inflammation causing blood-brain-barrier (BBB) damage and glial and neuronal activation leading to more inflammation and cell death is the most accepted theory behind delirium's pathophysiology. This study aims to evaluate the relationship between brain injury biomarkers on admission and delirium in acutely ill older patients. We performed a prospective cohort study which analyzed plasma S100B levels at admission in elderly patients. Our primary outcome was delirium diagnosis. Secondary outcomes were association between S100B, NSE and Tau protein and delirium diagnosis and patients' outcomes (admissions to intensive care, length of hospital stay, and in-hospital mortality). We analyzed 194 patients, and 46 (24%) developed delirium, 25 on admission and 21 during hospital stay. Median of S100B at admission in patients who developed delirium was 0.16 and median was 0.16 in patients who didn't develop delirium (p: 0.69). Levels S100B on admission did not predict delirium in acutely ill elderly patients.Trial registration: The study was approved by the local institutional review board (CAPPESq, no. 77169716.2.0000.0068, October 11, 2017) and registered in Brazilian Clinical Trials Registry (ReBEC, no. RBR-233bct).

Asunto(s)

Lesiones Encefálicas , Delirio , Humanos , Anciano , Estudios Prospectivos , Biomarcadores , Inflamación/complicaciones , Lesiones Encefálicas/complicaciones , Delirio/etiología

RESUMEN

Objetivo: Determinar el nivel de incertidumbre del cuidador familiar (CF) de la persona hos-pitalizada en fase terminal y su asociación con carga de síntomas y funcionalidad del paciente. Materiales y método: Estudio observacional de tipo corte transversal, donde se identificó la prevalencia de incertidumbre en el CF de pacientes hospitalizados en fase terminal usando la escala de incertidumbre. Adicionalmente, se evaluó la carga de síntomas mediante escala Edmonton del paciente terminal hospitalizado en una institución de salud de alta complejidad. Resultados: La muestra incluyó información de 69 CF y pacientes terminales hospitalizados. El 85,51% de los cuidadores tuvo un nivel de incertidumbre medio. Se observó un nivel es-tadísticamente significativo de incertidumbre menor en el CF, a mayor intensidad de dolor del paciente (p=0,04), al igual que en náuseas (p=0,0004), depresión (p=0,03) y ansiedad (p=0,025) según carga de síntomas. Discusión: La vivencia del cuidador de un paciente terminal, refle-jada en la incertidumbre frente a la enfermedad de este, se relaciona principalmente con la de-pendencia funcional del enfermo, debido probablemente al impacto que su falta de suficiencia puede generar en las rutinas diarias del cuidador familiar, lo cual, puede alterar completamente la dinámica familiar y generar sobrecarga, estrés, ansiedad y trastornos en la comunicación. Conclusión: La mayoría de CF de pacientes terminales son mujeres en edad productiva, con carga familiar, y con nivel de incertidumbre medio alto frente a la enfermedad del paciente. La incertidumbre del cuidador familiar es diferente según los síntomas que presenta el paciente.

---

Objective: To determine the level of uncertainty of the family caregiver (FC) of the terminally hospitalised person and its association with symptom burden and patient functionality. Mate-rials and methods: Observational cross-sectional study, in which the prevalence of uncertain-ty in the FC of terminally ill hospitalised patients was identified using the uncertainty scale. In addition, the symptom burden was assessed using the Edmonton scale in terminally ill patients hospitalised in a highly complex health institution. Results: The sample included information from 69 CF and terminally ill hospitalised patients. 85.51% of caregivers had a medium level of uncertainty. A statistically significant lower level of uncertainty was observed in the CF, the greater the intensity of the patient's pain (p=0.04), as well as in nausea (p=0.0004), de-pression (p=0.03) and anxiety (p=0.025) according to symptom burden. Discussion: The ex-perience of the caregiver of a terminally ill patient, reflected in the uncertainty of the patient's illness, is mainly related to the functional dependence of the patient, probably due to the impact that their lack of sufficiency can have on the daily routines of the family caregiver, which can completely alter the family dynamics and generate overload, stress, anxiety and communica-tion disorders. Conclusion: The majority of FC of terminally ill patients are women of produc-tive age, with a family burden, and with a medium-high level of uncertainty about the patient's illness. The uncertainty of the family caregiver is different according to the patient's symptoms

---

Objetivo: Determinar o nível de incerteza do cuidador familiar (CF) da pessoa hospitalizada em estado terminal e sua associação com a carga de sintomas e a funcionalidade do paciente. Mate-riais e métodos: Estudo observacional de corte transversal, no qual a prevalência de incerteza no CF de pacientes terminais hospitalizados foi identificada usando a escala de incerteza. Além dis-so, a carga de sintomas de pacientes terminais hospitalizados em uma instituição de saúde de alta complexidade foi avaliada usando a escala de Edmonton. Resultados: A amostra incluiu infor-mações de 69 pacientes com FC e pacientes terminais hospitalizados. 85,51% dos cuidadores tin-ham um nível médio de incerteza. Foi observado um nível de incerteza estatisticamente significa-tivo menor na FC quanto maior a intensidade da dor do paciente (p=0,04), bem como na náusea (p=0,0004), depressão (p=0,03) e ansiedade (p=0,025) de acordo com a carga de sintomas. Dis-cussão: A experiência do cuidador de um paciente terminal, refletida na incerteza da doença do paciente, está relacionada principalmente à dependência funcional do paciente, provavelmente devido ao impacto que sua falta de suficiência pode ter nas rotinas diárias do cuidador familiar, o que pode alterar completamente a dinâmica familiar e gerar sobrecarga, estresse, ansiedade e distúrbios de comunicação. Conclusão: A maioria dos CF de pacientes terminais são mulheres em idade produtiva, com ônus familiar e com um nível médio-alto de incerteza sobre a doença do paciente. A incerteza do cuidador familiar é diferente de acordo com os sintomas do paciente.

Asunto(s)

Enfermo Terminal , Cuidadores , Incertidumbre , Evaluación de Síntomas

RESUMEN

Abstract Background: Monocytes are essential components in inflammatory signaling, and their recruitment is crucial in the signaling pathway, which directs and determines cell adhesion to the activated endothelium. A better understanding of the correlation between monocyte subsets and inflammatory signaling in patients with atherosclerotic disease in acute coronary syndrome (ACS) is essential for the development of more effective therapies for the prevention and treatment of cardiovascular diseases. Objective: To analyze differences between biomarkers and monocyte activation in the setting of ischemic heart disease. Methods: This was a case-control study comparing biomarkers and monocyte subsets between patients with ACS with and without ST-segment elevation and individuals without coronary stenosis. The nonparametric Kruskal-Wallis test was used to assess differences between groups, and Dunn's post hoc test was used to identify which groups were different. Cuzick's test for ordered group trends was used to assess falling or rising trends. Participants were classified into 3 groups: control (0); non-ST-elevation myocardial infarction (NSTEMI) (1); ST-elevation myocardial infarction (STEMI) D1 (2). Results: Forty-seven patients with ACS and 19 controls with no obstructive lesions on coronary angiography were recruited. Monocyte profile assessment was statistically different regarding time of symptom onset and the presence or absence of atherosclerotic disease (Kruskal-Wallis, p = 0.0009). Dunn's post hoc test showed a significant difference between the control group and the STEMI D1 (p = 0.0014), STEMI D3 (p = 0.0036), and STEMI D7 (p = 0.0195) groups, corresponding to a 2-fold increase in classical (p = 0.0022) and nonclassical (p = 0.0031) monocytes compared with controls. For classical monocytes, there was a difference between the control group and all STEMI groups and between the NSTEMI group and the STEMI D1, D3, and D7 groups. For nonclassical monocytes, there was a difference between the control group and the STEMI D7 group (p = 0.0056) and between the NSTEMI group and the STEMI D7 group (p = 0.0166). Conclusion: This study found that there was an increase in total and classical monocyte mobilization at the time of acute myocardial infarction in patients with ACS.

RESUMEN

BACKGROUND: The decision to intubate COVID-19 patients receiving non-invasive respiratory support is challenging, requiring a fine balance between early intubation and risks of invasive mechanical ventilation versus the adverse effects of delaying intubation. This present study analyzes the association between intubation day and mortality in COVID-19 patients. METHODS: We performed a unicentric retrospective cohort study considering all COVID-19 patients consecutively admitted between March 2020 and August 2020 requiring invasive mechanical ventilation. The primary outcome was all-cause mortality within 28 days after intubation, and a Cox model was used to evaluate the effect of time from onset of symptoms to intubation in mortality. RESULTS: A total of 592 (20%) patients of 3020 admitted with COVID-19 were intubated during study period, and 310 patients who were intubated deceased 28 days after intubation. Each additional day between the onset of symptoms and intubation was significantly associated with higher in-hospital death (adjusted hazard ratio, 1.018; 95% CI, 1.005-1.03). CONCLUSION: Among patients infected with SARS-CoV-2 who were intubated and mechanically ventilated, delaying intubation in the course of symptoms may be associated with higher mortality. TRIAL REGISTRATION: The study protocol was approved by the local Ethics Committee (opinion number 3.990.817; CAAE: 30417520.0.0000.0068).

RESUMEN

Identification of the SARS-CoV-2 virus by RT-PCR from a nasopharyngeal swab sample is a common test for diagnosing COVID-19. However, some patients present clinical, laboratorial, and radiological evidence of COVID-19 infection with negative RT-PCR result(s). Thus, we assessed whether positive results were associated with intubation and mortality. This study was conducted in a Brazilian tertiary hospital from March to August of 2020. All patients had clinical, laboratory, and radiological diagnosis of COVID-19. They were divided into two groups: positive (+) RT-PCR group, with 2292 participants, and negative (-) RT-PCR group, with 706 participants. Patients with negative RT-PCR testing and an alternative most probable diagnosis were excluded from the study. The RT-PCR(+) group presented increased risk of intensive care unit (ICU) admission, mechanical ventilation, length of hospital stay, and 28-day mortality, when compared to the RT-PCR(-) group. A positive SARS-CoV-2 RT-PCR result was independently associated with intubation and 28 day in-hospital mortality. Accordingly, we concluded that patients with a COVID-19 diagnosis based on clinical data, despite a negative RT-PCR test from nasopharyngeal samples, presented more favorable outcomes than patients with positive RT-PCR test(s).

Asunto(s)

Prueba de Ácido Nucleico para COVID-19/estadística & datos numéricos , COVID-19/diagnóstico , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/estadística & datos numéricos , SARS-CoV-2/genética , Centros Médicos Académicos/estadística & datos numéricos , Anciano , Brasil , COVID-19/mortalidad , COVID-19/virología , Prueba de Ácido Nucleico para COVID-19/métodos , Femenino , Mortalidad Hospitalaria , Hospitalización/estadística & datos numéricos , Humanos , Unidades de Cuidados Intensivos/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Nasofaringe/virología , Estudios Retrospectivos , Factores de Riesgo

RESUMEN

OBJECTIVES: Prior studies have examined sleep during the coronavirus disease 2019 (COVID-19) pandemic, but have few compared sleep measured both during and prior to COVID. We examined the impact of the COVID-19 pandemic on subjective sleep quality in general and separately by gender and age (<50 vs. ≥50 years). Further, we compared sleep quality between those who did and did not follow quarantine orders. METHODS: This sample is from the Baependi Heart Study, a family-based cohort of adults in South-eastern Brazil. Longitudinal data were from 417 individuals who completed the Pittsburgh Sleep Quality Index (PSQI) twice: between January 2010 and September 2014 (pre-COVID) and during the COVID-19 stay-at-home order March-June, 2020. Cross-sectional analysis included 800 participants. RESULTS: Mean (±SD) PSQI scores were significantly higher during than before COVID-19 (5.7 ± 3.8 vs. 5.0 ± 3.3, p < .01). This increase was significant among women and among adults ≥50 years but not in men or younger adults. The significant increase in PSQI was only observed in those who quarantined during COVID-19 (5.9 ±3.7 vs. 5.2 ±3.4, p < .01) and not those who did not quarantine (5.0 ± 3.7 vs. 4.5 ± 3, p = .12). In cross-sectional analyses, individuals who quarantined had higher PSQI scores than nonquarantined individuals (6.1 ± 3.9 vs. 5.0 ± 3.5, p < .01). The quarantine status-dependent differences were significant for women (6.4 ± 4 vs. 5.2 ± 3.7, p < .01) and older adults (6.6 ± 0.1 vs. 5.5 ± 3.3, p = .04). Differences by quarantine status were attenuated after adjusting for age and gender. CONCLUSIONS: Subjective sleep quality declined during the COVID-19 pandemic, particularly among women, older adults, and those compliant to quarantine orders.

Asunto(s)

COVID-19 , Anciano , Brasil/epidemiología , Estudios Transversales , Femenino , Humanos , Masculino , Pandemias , Población Rural , SARS-CoV-2 , Calidad del Sueño

RESUMEN

The role of innate immunity in COVID-19 is not completely understood. Therefore, this study explored the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection on the expression of Pattern Recognition Receptors (PRRs) in peripheral blood cells and their correlated cytokines. Seventy-nine patients with severe COVID-19 on admission, according to World Health Organization (WHO) classification, were divided into two groups: patients who needed mechanical ventilation and/or deceased (SEVERE, n = 50) and patients who used supplementary oxygen but not mechanical ventilation and survived (MILD, n = 29); a control group (CONTROL, n = 17) was also enrolled. In the peripheral blood, gene expression (mRNA) of Toll-like receptors (TLRs) 3, 4, 7, 8, and 9, retinoic-acid inducible gene I (RIGI), NOD-like receptor family pyrin domain containing 3 (NLRP3), interferon alpha (IFN-α), interferon beta (IFN-ß), interferon gamma (IFN-γ), interferon lambda (IFN-λ), pro-interleukin(IL)-1ß (pro-IL-1ß), and IL-18 was determined on admission, between 5-9 days, and between 10-15 days. Circulating cytokines in plasma were also measured. When compared to the COVID-19 MILD group, the COVID-19 SEVERE group had lower expression of TLR3 and overexpression of TLR4.

Asunto(s)

COVID-19/diagnóstico , COVID-19/genética , Regulación de la Expresión Génica , Receptor Toll-Like 3/sangre , Receptor Toll-Like 3/genética , Anciano , COVID-19/sangre , COVID-19/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Respiración Artificial

RESUMEN

BACKGROUND: The first cases of coronavirus disease (COVID-19) in Brazil were diagnosed in February 2020. Our Emergency Department (ED) was designated as a COVID-19 exclusive service. We report our first 500 confirmed COVID-19 pneumonia patients. METHODS: From 14 March to 16 May 2020, we enrolled all patients admitted to our ED that had a diagnosis of COVID-19 pneumonia. Infection was confirmed via nasopharyngeal swabs or tracheal aspirate PCR. The outcomes included hospital discharge, invasive mechanical ventilation, and in-hospital death, among others. RESULTS: From 2219 patients received in the ED, we included 506 with confirmed COVID-19 pneumonia. We found that 333 patients were discharged home (65.9%), 153 died (30.2%), and 20 (3.9%) remained in the hospital. A total of 300 patients (59.3%) required ICU admission, and 227 (44.9%) needed invasive ventilation. The multivariate analysis found age, number of comorbidities, extension of ground glass opacities on chest CT and troponin with a direct relationship with all-cause mortality, whereas dysgeusia, use of angiotensin converting enzyme inhibitor or angiotensin-ii receptor blocker and number of lymphocytes with an inverse relationship with all-cause mortality. CONCLUSIONS: This was a sample of severe patients with COVID-19, with 59.2% admitted to the ICU and 41.5% requiring mechanical ventilator support. We were able to ascertain the outcome in majority (96%) of patients. While the overall mortality was 30.2%, mortality for intubated patients was 55.9%. Multivariate analysis agreed with data found in other studies although the use of angiotensin converting enzyme inhibitor or angiotensin-ii receptor blocker as a protective factor could be promising but would need further studies. TRIAL REGISTRATION: The study was registered in the Brazilian registry of clinical trials: RBR-5d4dj5.

Asunto(s)

COVID-19/mortalidad , COVID-19/terapia , Anciano , Brasil/epidemiología , COVID-19/epidemiología , Estudios de Cohortes , Servicio de Urgencia en Hospital , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estaciones del Año

RESUMEN

BACKGROUND: A local increase in angiotensin 2 after inactivation of angiotensin-converting enzyme 2 by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce a redox imbalance in alveolar epithelium cells, causing apoptosis, increased inflammation and, consequently, impaired gas exchange. We hypothesized that N-acetylcysteine (NAC) administration could restore this redox homeostasis and suppress unfavorable evolution in patients with coronavirus disease 2019 (COVID-19). METHODS: This was a double-blind, randomized, placebo-controlled, single-center trial conducted at the Emergency Department of Hospital das Clínicas, São Paulo, Brazil, to determine whether NAC in high doses can avoid respiratory failure in patients with COVID-19. We enrolled 135 patients with severe COVID-19 (confirmed or suspected), with an oxyhemoglobin saturation <94% or respiratory rate >24 breaths/minute. Patients were randomized to receive NAC 21 g (~300 mg/kg) for 20 hours or dextrose 5%. The primary endpoint was the need for mechanical ventilation. Secondary endpoints were time of mechanical ventilation, admission to the intensive care unit (ICU), time in ICU, and mortality. RESULTS: Baseline characteristics were similar between the 2 groups, with no significant differences in age, sex, comorbidities, medicines taken, and disease severity. Also, groups were similar in laboratory tests and chest computed tomography scan findings. Sixteen patients (23.9%) in the placebo group received endotracheal intubation and mechanical ventilation, compared with 14 patients (20.6%) in the NAC group (P = .675). No difference was observed in secondary endpoints. CONCLUSIONS: Administration of NAC in high doses did not affect the evolution of severe COVID-19. CLINICAL TRIALS REGISTRATION: Brazilian Registry of Clinical Trials (REBEC): U1111-1250-356 (http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/).

Asunto(s)

Tratamiento Farmacológico de COVID-19 , Acetilcisteína/uso terapéutico , Brasil , Método Doble Ciego , Humanos , Respiración Artificial , SARS-CoV-2 , Resultado del Tratamiento

RESUMEN

Resistant hypertension (RH) is defined as uncontrolled blood pressure despite treatment with three or more antihypertensive medications, including, if tolerated, a diuretic in adequate doses. It has been widely known that race is associated with blood pressure control. However, intense debate persists as to whether this is solely explained by unadjusted socioeconomical variables or genetic variation. In this scenario, the main aim was to evaluate the association between genetic ancestry and resistant hypertension in a large sample from a multicenter trial of stage II hypertension, the ReHOT study. Samples from 1,358 patients were analyzed, of which 167 were defined as resistant hypertensive. Genetic ancestry was defined using a panel of 192 polymorphic markers. The genetic ancestry was similar in resistant (52.0% European, 36.7% African and 11.3% Amerindian) and nonresistant hypertensive patients (54.0% European, 34.4% African and 11.6% Amerindian) (p > 0.05). However, we observed a statistically suggestive association of African ancestry with resistant hypertension in brown patient group. In conclusion, increased African genetic ancestry was not associated with RH in Brazilian patients from a prospective randomized hypertension clinical trial.

Asunto(s)

Vasoespasmo Coronario/genética , Hipertensión/genética , Población Negra/genética , Brasil/epidemiología , Vasoespasmo Coronario/epidemiología , Femenino , Estudios de Asociación Genética , Marcadores Genéticos , Humanos , Hipertensión/epidemiología , Indígenas Sudamericanos/genética , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Estudios Prospectivos , Población Blanca/genética

RESUMEN

BACKGROUND AND AIMS: Carotid intima-media thickness (cIMT) is a strong predictor of cardiovascular events and associated with metabolic syndrome (MetS). MetS is a cluster of cardiovascular risk factors, but the association structure between specific factors and disease development is not well-established in rural populations. We described the association structure between MetS factors and cIMT in a sample from rural Brazil. METHODS: We studied 1937 participants from the Baependi Heart Study who underwent carotid ultrasound exam. We used ATP-III-2001 for MetS definition and linear mixed-effects models, adjusting by the family structure, to assess independent associations between the cardiovascular risk factors which define MetS and cIMT. RESULTS: The sample's mean age was 46 ± 16y, 61% female, 73% white, mean body-mass-index 26±5 kg/m2, mean cIMT 0.53 ± 0.16 mm, with 35% of the sample classified with MetS. As expected, cIMT demonstrated a linear relationship with increasing age, and cIMT higher values were observed for MetS (0.58 ± 0.16 mm) compared to non-MetS (0.49 ± 0.14 mm). Considering models for cIMT with MetS and all of its factors, we found that blood pressure, glucose and obesity were independently associated with cIMT, but not HDL or triglycerides. CONCLUSIONS: cIMT showed a linear relationship with increasing age. Blood pressure, obesity, and glucose were independently associated with cIMT, but not HDL-cholesterol or triglycerides. In a rural population, hypertension, diabetes and obesity play a more important role than lipids in determining cIMT interindividual variability.

RESUMEN

Abstract Background: Genetic cascade screening is the most cost-effective method for the identification of individuals with familial hypercholesterolemia (FH), but the best strategies for the enrollment of at-risk individuals in a FH screening program are not fully known. Objective: The aim of this study is to identify the best predictors of familial enrollment into genetic screening, using features derived from tested probands. Methods: One hundred and eighty-three index-cases (ICs) with a positive genetic result that had relatives screened from 01/2011 to 07/2015 were included. The response variable was the number of relatives for each enrolled IC. All variables in the study were based on ICs' derived clinical and socioeconomical features. The effect size of predictor variables were obtained through a general linear model using a negative binomial regression link function. Significance was considered with a p < 0.05. Results: Mean IC age when enrolling into the program was 50 years old; 78.1% of individuals reported knowledge of relatives with dyslipidemia. Mean baseline LDL-cholesterol level was 316 ± 90 mg/dL. Referral origin through the cascade program website vs. tertiary care, IC LDL-cholesterol and familial history of high LDL-cholesterol levels were independent predictors associated with a higher number of enrolled relatives. Conclusions: Our data suggest that FH cascade screening programs can predict family enrollment based on IC features. This information may be useful for devising better and more effective screening approaches for at-risk individuals.

---

Resumo Fundamento: O rastreamento genético em cascata é o método mais economicamente viável para a identificação de indivíduos com hipercolesterolemia familiar, mas as melhores estratégias para o recrutamento de indivíduos em risco em um programa de rastreamento deste tipo não são inteiramente conhecidas. Objetivo: Identificar os melhores preditores de recrutamento familiar em rastreamento genético, usando características derivadas de probandos testados. Métodos: Foram inscritos 183 casos índices com resultado genético positivo, que tiveram familiares rastreados de janeiro de 2011 a julho de 2015. A variável de resposta foi o número de familiares para cada caso índice inscrito. Todas as variáveis do estudo foram baseadas em características clínicas e socioeconômicas derivadas dos casos índices. O tamanho do efeito das variáveis preditoras foi obtido de modelo linear geral utilizando função de associação de regressão binomial negativa. A significância foi considerada com p < 0,05. Resultados: A média de idade dos casos índices ao ingressar no programa foi de 50 anos; 78,1% dos indivíduos relataram conhecimento de familiares com dislipidemia. O nível médio de LDL-colesterol inicial foi de 316 ± 90 mg/dL. Origem de referência por meio do site do programa em cascata vs. cuidados terciários, LDL-colesterol do caso índice e história familiar de níveis elevados de LDL-colesterol foram preditores independentes associados a um maior número de familiares inscritos. Conclusões: Programas de rastreamento genético em cascata da hipercolesterolemia familiar podem prever o recrutamento da família com base nas características do caso índice. Esta informação pode ser útil para criar abordagens de rastreamento melhores e mais eficazes para indivíduos em risco.

Asunto(s)

Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Familia , Pruebas Genéticas/métodos , Selección de Paciente , Hiperlipoproteinemia Tipo II/genética , Valores de Referencia , Brasil , Modelos Lineales , Tamizaje Masivo/métodos , Análisis de Regresión , Factores de Riesgo , Diagnóstico Precoz , Hiperlipoproteinemia Tipo II/diagnóstico

RESUMEN

BACKGROUND: Genetic cascade screening is the most cost-effective method for the identification of individuals with familial hypercholesterolemia (FH), but the best strategies for the enrollment of at-risk individuals in a FH screening program are not fully known. OBJECTIVE: The aim of this study is to identify the best predictors of familial enrollment into genetic screening, using features derived from tested probands. METHODS: One hundred and eighty-three index-cases (ICs) with a positive genetic result that had relatives screened from 01/2011 to 07/2015 were included. The response variable was the number of relatives for each enrolled IC. All variables in the study were based on ICs' derived clinical and socioeconomical features. The effect size of predictor variables were obtained through a general linear model using a negative binomial regression link function. Significance was considered with a p < 0.05. RESULTS: Mean IC age when enrolling into the program was 50 years old; 78.1% of individuals reported knowledge of relatives with dyslipidemia. Mean baseline LDL-cholesterol level was 316 ± 90 mg/dL. Referral origin through the cascade program website vs. tertiary care, IC LDL-cholesterol and familial history of high LDL-cholesterol levels were independent predictors associated with a higher number of enrolled relatives. CONCLUSIONS: Our data suggest that FH cascade screening programs can predict family enrollment based on IC features. This information may be useful for devising better and more effective screening approaches for at-risk individuals.

Asunto(s)

Familia , Pruebas Genéticas/métodos , Hiperlipoproteinemia Tipo II/genética , Selección de Paciente , Adulto , Anciano , Brasil , Diagnóstico Precoz , Femenino , Humanos , Hiperlipoproteinemia Tipo II/diagnóstico , Modelos Lineales , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Valores de Referencia , Análisis de Regresión , Factores de Riesgo

RESUMEN

Coronary artery calcification (CAC) is a widespread condition in chronic kidney disease (CKD). Diet may play an important role in CAC, but this role is not clear. This study evaluated the association between macro-and micronutrient intakes and CAC in non-dialysis CKD patients. We analyzed the baseline data from 454 participants of the PROGREDIR study. Dietary intake was evaluated by a food frequency questionnaire. CAC was measured by computed tomography. After exclusion of participants with a coronary stent, 373 people remained for the analyses. The highest tertile of CAC was directly associated with the intake of phosphorus, calcium and magnesium. There was a higher intake of pantothenic acid and potassium in the second tertile. After adjustments for confounding variables, the intake of pantothenic acid, phosphorus, calcium and potassium remained associated with CAC in the generalized linear mixed models. In order to handle the collinearity between these nutrients, we used the LASSO (least absolute shrinkage and selection operator) regression to evaluate the nutrients associated with CAC variability. In this approach, the nutrients that most explained the variance of CAC were phosphorus, calcium and potassium. Prospective studies are needed to confirm these findings and assess the role of interventions regarding these micronutrients on CAC prevention and progression.

Asunto(s)

Enfermedad de la Arteria Coronaria/etiología , Dieta/efectos adversos , Insuficiencia Renal Crónica/complicaciones , Calcificación Vascular/etiología , Anciano , Brasil , Calcio de la Dieta/efectos adversos , Distribución de Chi-Cuadrado , Angiografía por Tomografía Computarizada , Angiografía Coronaria/métodos , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Estudios Transversales , Femenino , Humanos , Modelos Lineales , Magnesio/efectos adversos , Masculino , Persona de Mediana Edad , Tomografía Computarizada Multidetector , Análisis Multivariante , Ácido Pantoténico/efectos adversos , Fósforo Dietético/efectos adversos , Insuficiencia Renal Crónica/diagnóstico , Factores de Riesgo , Encuestas y Cuestionarios , Calcificación Vascular/diagnóstico por imagen

RESUMEN

El pioderma gangrenoso es una enfermedad inflamatoria crónica, poco común, con una incidencia de 3 a 10 casos por millón de habitantes, su etiología aún se desconoce pero se ha asociado con múltiples condiciones sistémicas dentro de las que sobresale la enfermedad inflamatoria intestinal. Hasta el momento se conocen cuatro variantes clínicas y la más común de todas es la forma ulcerativa. El diagnóstico es principalmente clínico y de descarte. En la histología se caracteriza por un infiltrado neutrofílico de la dermis. El tratamiento de elección son los glucocorticoides orales, aunque hay otras opciones terapéuticas descritas. Reportamos un caso representativo de un pioderma gangrenoso ulcerativo asociado con enfermedad inflamatoria intestinal.

---

Pyoderma gangrenosum is a chronic inflammatory disease, uncommon, with an incidence of 3 to 10 cases per million inhabitants, whose etiology remains unknown but has been associated with multiple systemic conditions in which stands out inflammatory bowel disease. So far, four clinical variants are known to be the most common ulcerative form of all. The diagnosis is mainly clinical and of discard. In histology its characterized by a neutrophilic infiltrate in the dermis. The treatment of choice is oral corticosteroids, although there are many other therapeutic options described. we report a representative case of an ulcerative pyoderma gangrenosum associated with inflammatory bowel disease

Asunto(s)

Humanos , Piodermia Gangrenosa , Colitis Ulcerosa , Enfermedades Inflamatorias del Intestino

RESUMEN

Introducción. La sensibilidad de las pruebas convencionales (examen directo, cultivo) para el diagnóstico de la onicomicosis (25 a 80%), representa un problema para la decisión terapéutica del dermatólogo. Objetivo. Determinar la exactitud diagnóstica de la muestra de la lámina ungular en pacientes con diagnóstico clínico de onicomicosis. Metodología. Es un estudio prospectivo de pruebas diagnósticas en 50 pacientes con sospecha de onicomicosis. Se tomó muestra de la lámina ungular con cortaúñas estéril en el área de onicólisis para pruebas micológicas (KOHcultivo) y de histopatología (hematoxilina y eosina y ácido peryódico de Schiff), y muestra de detritos mediante raspado del lecho para prueba micológica. La toma de muestras y el procesamiento de las pruebas se realizaron en laboratorios de referencia y se interpretaron de manera ciega e independiente. La muestra de detritos se consideró la prueba estándar. Resultados. Se observó compromiso de los pies en 90% de los pacientes, 86,6% con afectación del primer dedo. La prueba micológica de detritos fue positiva en 80% de los casos, encontrándose estructuras micóticas en el examen directo en 72% y aislamiento al cultivo en 64%. En la lámina ungular, la sensibilidad fue de 87,5% y la especificidad de 80%; el cociente de probabilidades positivo fue 4,4. Cinco muestras positivas con la tinción PAS fueron negativas en la prueba estándar. La sensibilidad neta aumentó a 95% mediante el análisis de las pruebas en paralelo de la lámina ungular. La mayoría de los aislamientos fueron especies de Candida (77,3% en detritos y 75,9% en la lámina ungular), y C. parapsilosis fue el aislamiento más frecuente. Conclusión. Se propone la muestra de la lámina ungular para pruebas micológicas y tinción de PAS, como complemento a la muestra de detritos para el diagnóstico de onicomicosis.

Asunto(s)

Dermatosis del Pie , Onicomicosis/diagnóstico

RESUMEN

La candidiasis mucocutánea es una infección superficial común en nuestro medio, con múltiples factores de riesgo para su desarrollo. En las últimas décadas se ha incrementado su presentación, ya que tiene gran asociación con el VIH-sida, aunque también se presenta en personas inmunocompetentes. El agente etiológico más común es Candida albicans. La candidiasis superficial puede comprometer piel, mucosas y uñas, y existe la forma mucocutánea crónica que se asocia a enfermedades autoinmunitarias. Se hace una revisión de las principales formas de candidiasis mucocutánea y su implicación clínica en la población general.

Asunto(s)

Candida albicans , Candidiasis Mucocutánea Crónica , Candidiasis Cutánea , Candidiasis Bucal , Huésped Inmunocomprometido , Inmunosupresores

RESUMEN

Introducción. Entre los síntomas que con mayor frecuencia presentan los pacientes con enfermedad renal crónica terminal en la terapia de reemplazo renal de tipo hemodiálisis y diálisis peritoneal, se encuentra el prurito urémico. Objetivo. Comparar la efectividad de los emolientes con la de la gabapentina en el manejo del prurito urémico y el impacto en la calidad de vida en los pacientes con enfermedad renal crónica terminal en terapia de reemplazo renal de tipo hemodiálisis y diálisis peritoneal, en el Servicio de Terapia Renal del Hospital Pablo Tobón Uribe, entre enero y abril de 2010. Metodología. Se realizó un ensayo clínico controlado de asignación aleatoria, sin cegamiento, en el que se administraron tratamientos con emolientes o gabapentina a grupos de pacientes con insuficiencia renal crónica y prurito, que acudieron al Servicio de Terapia Renal del Hospital Pablo Tobón Uribe, para recibir terapia de reemplazo renal, ya fuera hemodiálisis o diálisis peritoneal. Resultados. En ambos grupos se observó mejoría sustancial del prurito. En 15 pacientes que fueron tratados con gabapentina, se encontró una disminución de la intensidad del prurito, medido por la escala visual análoga, pasando de una media de 6,6 al inicio a una de 1,1 al final. Del mismo modo ocurrió con los 18 pacientes del grupo que recibió emolientes, pasando de una media de 5,2 al inicio a una de 1,3 al final. Con respecto a la evaluación de la calidad de vida, se observó diferencia únicamente para el dominio de la funcionalidad social en el grupo de emolientes entre la primera y segunda evaluación, sin apreciarse diferencias significantes en el grupo de gabapentina. Conclusión. Los pacientes experimentaron una mejoría estadísticamente significativa en el prurito con los dos tratamientos; sin embargo, cuando se compararon, no se observó diferencia significativa, por lo que no se puede aseverar, con el tamaño de muestra obtenido, que un tratamiento sea mejor que el otro. En cuanto a la calidad de vida, únicamente en el grupo de emolientes se apreció mejoría en el dominio de funcionalidad social.

Asunto(s)

Antipruriginosos , Emolientes , Fallo Renal Crónico , Diálisis Peritoneal , Prurito/terapia , Diálisis Renal , Uremia

RESUMEN

El liquen plano ungular es una dermatosis inflamatoria crónica cuyo tratamiento es obligatorio para evitar la cicatrización de la matriz de la uña; sin embargo, no hay estándares definidos de tratamiento. En este artículo reportamos el caso de una mujer con liquen plano ungular con distrofia de las 20 uñas, tratada exitosamente con isotretinoína oral, biotina oral y lactato de amonio tópico al 12%.

Asunto(s)

Isotretinoína , Liquen Plano , Enfermedades de la Uña

RESUMEN

La alopecia areata es una forma común de alopecia no cicatricial, recurrente, que causa pérdida del pelo. Los jóvenes y los niños están comúnmente afectados, pero es rara su aparición en neonatos. Presentamos el caso de una paciente con alopecia neonatal, que respondió favorablemente al tratamiento tópico con tacrolimus.

Asunto(s)

Recién Nacido , Alopecia Areata , Alopecia Areata/terapia , Tacrolimus/uso terapéutico